Welcome Message

We are deep in conference season with both the TSANZSRS18 and the ATS Congress now finished for another year. At TSANZSRS18, respiratory research received a much needed boost of over $2 million funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and we hope you enjoyed this new -look celebration. You can recap the TSANZ research winners on our website. ATS Congress was another huge event and we invite you to look at the limbic stories below for highlights. The next international meeting in the respiratory circuit is the ERS Congress in Paris Sept 15-19. There are ERS travel awards available still so please look into these if you are planning on attending. 

We would also like to highlight the funding opportunities available for those researching alpha-one antitrypsin deficiency in lung disease. There are large grants on offer from the Alpha One Association and these do not require any specific membership and international collaborations for eligibility.

Furthermore, the Thoracic Society Research Medal and other awards by nominations are now open. Please consider nominating a member in recognition of their outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand.

Finally, I encourage you all to complete the survey at the end of this newsletter in regards to The Global Lung Function Initiative (GLI). The GLI has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations. They are now seeking feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation.

Enjoy the June edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

TSANZ NZ Branch ASM Travel Grant - closing 14 Jul 18

Vertex Cystic Fibrosis Research Awards - NACFC closing 08 Aug 18

Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards - ERS closing 29 Jun 18, APSR closing 09 Jul 18

        

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements...

Support TSANZ

This year, TSANZ is asking members to provide a tax deductible donation to support our work in respiratory research and/or clinical care. You can choose to donate to one, or both, of the programs detailed below:

1. TSANZ 50th Anniversary Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor. In 2018, this program supported the development of two clinical programs:

  • Take the Bronchiectasis Toolbox on the road: A program aiming to build upon the tremendous work of the Bronchiectasis Toolbox by increasing its effectiveness in in Australia’s regional and remote areas. TBTR is designed to bridge the gap between electronic platform and clinician by supplementing the Toolbox’s online content with face-to-face educational workshops, as well as further online resources and telephone and email support.
  • A clinician’s guide to early diagnosis of PCD – when common symptoms mean so much more!: An online educational resource for medical staff to aid in the early and accurate diagnosis of Primary Ciliary Dyskinesia (PCD). This resource aims to increase medical awareness of suggestive symptoms as well as referral directions for diagnostic testing. This guide will not only better enable clinicians to identify PCD in its crucial early stages, but provide them with the knowledge of specific PCD therapy aims that they need to ensure their patients receive the best treatment possible.

 - CLICK HERE to make a donation.

2. Joint TSANZ/LFA Research Program

In 2018 were able to recognise three respiratory health researchers for their work in combating serious lung disease. The 2018 Lungs for Life Research Award winners were:

Professor Phil Hansbro: Cell free microRNA: potential biomarkers for the early detection of lung cancer

Dr Malcolm Starkey: Understanding how group 2 innate lymphoid cells in early-life regulate postnatal lung development and susceptibility to chronic lung diseases

Dr Megan Jensen: Maternal and Early Life Vitamin D exposure and asthma risk in high risk infants

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease. Please CLICK HERE to make a donation.

3. Leave TSANZ a gift in your will – If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy. If interested, please notify us by ticking the box on the Support TSANZ form attached. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

4. TSANZ New Zealand Branch Incorporated - CLICK HERE to make a donation.

New Zealand members are able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.

TSANZ Medals  

We apologise for the mistake we made in our latest article on the Society Medal in the May e-news. In response, we would like to congratulate the recipients of three prestigious TSANZ Medals: the Society Medal, the Research Medal, and the 50th Anniversary Medal. These awards are presented to TSANZ members as an acknowledgement of their outstanding contributions to respiratory health in research, education, and the health sector.

Nominations for the year have now opened! If you wish to nominate an extraordinary TSANZ member for their work in respiratory health, please visit https://www.thoracic.org.au/researchawards/tsanz-awards-by-nomination for more information.

Previous recipients of these prestigious TSANZ Medals are listed below:

The Research Medal

1992 Professor Ludwig Engel (posthumously) 
1994 Professor Colin Sullivan
1996
Professor Terry Nicholas
Professor Peter Phelan
1998 Professor Judith Black
1999 A/Professor Philip Thompson
2000 Professor Richard Beasley
2003 A/Professor Peter Gibson
2005 Professor Peter Sly
2006 A/Professor Gary Anderson
2007 Professor Haydn Walters
2008 Professor Bruce Robinson
2009 Professor Peter Bye
2010
Professor Guy Marks
2011
Professor Bill Musk
Professor Michael Abramson
2012 A/Professor Paul Forrest
2013 Professor Anne Chang
2014 Professor Scott Bell
2015 Professor Richard Beasley
2016 Professor Ron Grunstein
2018 Professor Peter Le Souef

 

 

The Society Medal

1992 Dr Maurice Joseph
1993 Dr Roy Mills
1994 Professor Tom O’Donnell
1995 Dr Michael Pain
1996 Dr Alastair Campbell (posthumously)
1997 Dr Michael Burns
1998 Professor Ann Woolcock
1999 Dr Kevin Finucane
2002 Dr Peter Rothwell
2004 Dr Abraham Rubinfeld
2006 A/Professor Charles Mitchell
2008 Dr Bob Edwards
2011 Judge John O’Meally
2012 Professor Norbert Berend
2013 Professor Philip Thompson
2014 Professor Peter van Asperen
2015 Professor Martin Phillips
2016 Professor Iven Young
2017 Professor Peter Holmes
2018 Professor Paul Reynolds

 

50th Anniversary Medal

2011 Dr Paul Zimmerman 
2012
A/Professor Tara Mackenzie 
2013 Professor Fiona Lake
2014 A/Professor Chien-Li Holmes-Liew 
2015 Professor Hubertus Jersmann
Dr Nicholas Saltos
2016 Professor Peter Frith
2017 Professor Jennifer Alison
Professor Richard Ruffin

 

Respirology Issue - Editor’s Choice

Vitamin D and respiratory health in the Busselton Healthy Ageing Study

SIOBHAIN MULRENNAN, MATTHEW KNUIMAN, JOHN P. WALSH, JENNIE HUI, MICHAEL HUNTER, MARK DIVITINI, KUN ZHU, BRIAN R. COOKE, ARTHUR W. (BILL) MUSK and ALAN JAMES

DOI: 10.1111/resp.13239

A Busselton Health Study participant undergoing lung function testing

 

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema

JOSEPH JACOB, BRIAN J. BARTHOLMAI, SRINIVASAN RAJAGOPALAN, RONALD KARWOSKI, ARJUN NAIR, SIMON L.F. WALSH, JOSEPH BARNETT, GARY CROSS, EOIN P. JUDGE, MARIA KOKOSI, ELISABETTA RENZONI, TOBY M. MAHER and ATHOL U. WELLS

DOI: 10.1111/resp.13231

The Royal Brompton Hospital in South Kensington, London, UK (left), and the Mayo Clinic in Rochester,  MN, USA  (right).

 

Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

JUNYA OKUMURA, YUICHIRO SHINDO, KUNIHIKO TAKAHASHI, MASAHIRO SANO, YASUTERU SUGINO, TETSUYA YAGI, HIROYUKI TANIGUCHI, HIDEO SAKA, SHIGEYUKI MATSUI, YOSHINORI HASEGAWA on behalf of the Central Japan Lung Study Group

DOI: 10.1111/resp.13232

The Nagoya University Respiratory Tract Infection Team studied approximately 1500 patients with pneumonia from 10 different hospitals on behalf of the Central Japan Lung Study Group.

 

Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease 

LASZLO T. VASZAR, BRANDON T. LARSEN, KAREN L. SWANSON, JAY H. RYU AND HENRY D. TAZELAAR

DOI: 10.1111/resp.13223

The research team from the Mayo Clinics in Scottsdale, AR, and Rochester, MN, USA, from left to right: Karen L Swanson, Henry D Tazelaar, Laszlo T Vaszar, Brandon T Larsen and Jay H Ryu (inset top right).

 

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial

STEVEN MCKINSTRY, JANINE PILCHER, GEORGE BARDSLEY, JAMES BERRY, SUSANNE VAN DE HEI, IRENE BRAITHWAITE, JAMES FINGLETON, MARK WEATHERALL and RICHARD BEASLEY

DOI: 10.1111/resp.13185

Nasal High Flow therapy in action

 

Pharmacokinetics and safety of paclitaxel delivery into porcine airway walls by a new endobronchial drug delivery catheter

HISASHI TSUKADA, PLAMENA ENTCHEVA-DIMITROV, ARMIN ERNST, SAMAAN RAFEQ, JOHN H. KEATING, KIRK P. SEWARD and LONNY YARMUS

DOI: 10.1111/resp.13214

The Blowfish® Transbronchial Micro-Infusion Catheter

Research Project and Survey Requests

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

Explaining chronic breathlessness

Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

For further information or to participate, please click here: 

Explain chronic breathlessness’   or copy and paste the following into your browser:

https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)